Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Molecular Pharmacology|September 7, 2007
Are alpha9alpha10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins?S T Nevin, R J Clark, H Klimis, et al.
The Journal of Biological Chemistry|May 19, 2009
Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptorReena Halai, Richard J Clark, Simon T Nevin, et al.
FEBS Letters|February 5, 2008
The three-dimensional structure of the analgesic alpha-conotoxin, RgIARichard J Clark, Norelle L Daly, Reena Halai, et al.
The Journal of Biological Chemistry|May 13, 2003
Insights into the structural basis for zinc inhibition of the glycine receptorSimon T Nevin, Brett A Cromer, Justine L Haddrill, et al.
The Journal of Biological Chemistry|February 28, 2006
Alpha-selenoconotoxins, a new class of potent alpha7 neuronal nicotinic receptor antagonistsChristopher J Armishaw, Norelle L Daly, Simon T Nevin, et al.
Biochemical Pharmacology|August 8, 2014
Hydrophobic residues at position 10 of α-conotoxin PnIA influence subtype selectivity between α7 and α3β2 neuronal nicotinic acetylcholine receptorsGene Hopping, C-I Anderson Wang, Ron C Hogg, et al.
The Journal of Biological Chemistry|June 23, 2006
Identification of a novel class of nicotinic receptor antagonists: dimeric conotoxins VxXIIA, VxXIIB, and VxXIIC from Conus vexillumMarion Loughnan, Annette Nicke, Alun Jones, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|July 8, 2016
Management of radioactive waste gases from PET radiopharmaceutical synthesis using cost effective capture systems integrated with a cyclotron safety systemD H R Stimson, A J Pringle, D Maillet, et al.
Antioxidants & Redox Signaling|May 22, 2010
Stabilization of α-conotoxin AuIB: influences of disulfide connectivity and backbone cyclizationErica S Lovelace, Sunithi Gunasekera, Charlotta Alvarmo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 31, 1999
Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3 (ACTG 261). ACTG 261 TeamG H Friedland, R Pollard, B Griffith, et al.
Pageof 5